Fungal infection in the immunocompromised patient. Dr Kirsty Dodgson

Size: px
Start display at page:

Download "Fungal infection in the immunocompromised patient. Dr Kirsty Dodgson"

Transcription

1 Fungal infection in the immunocompromised patient Dr Kirsty Dodgson

2 Aims Discuss different types of fungi Overview of types of clinical infections Clinical Manifestations

3 Fungus Includes Moulds Aspergillus Fusarium Dematiaceaous moulds e.g. Exophiala Mucoraceous moulds e.g. Rhizopus Yeasts Candida Pneumocystis Cryptococcus

4 Epidemiology Moulds are everywhere We breathe them in constantly Soil, vegetation Warm moist humid environments Neutropenic diet tries to reduce risk Crisps Pepper

5

6 Candida albicans Most common species isolated from superficial sites and blood. Most pathogenic species. Sensitive to most antifungal agents.

7 Non-albicans Candida species Many different species, very heterogeneous. Generally: Increasing frequency- multifactorial explanation. Probably less pathogenic than C. albicans. Often more resistant than C. albicans.

8 Changing Epidemiology ing aggressive therapy, leads to more susceptible patients. Ageing population more susceptible patients Use of prophylactic fluconazole leads to decrease in susceptible sp (e.g. albicans) and replacement with resistant sp (e.g. glabrata).

9 Skin and mucosa Asymptomatic colonisation Cutaneous candidiasis Chronic mucocutaneous candidiasis Oesophagitis Onychomycosis Oropharyngeal candidiasis Vulvovaginitis

10 Oesophagitis

11 Thrush Assocoiated with decrease in normal flora Watch for recurrent cases If occur perform ID and susceptibilities

12 Invasive Candidiasis Candidaemia Intravascular Catheters Disseminated candidiasis

13 Hepatosplenic Candidiasis Within the four overlapping forms of invasive candidiasis, there is a distinct clinical picture that has been given a variety of names: Chronic Disseminated Candidiasis (CDC) Hepatosplenic Candidiasis, Hepatic Candidiasis and Granulomatous Hepatitis. However, the other terms are equally valid.

14 Interestingly this is a condition that affects almost exclusively patients undergoing remission induction chemotherapy or bone marrow transplantation for acute leukemia HS Candidiasis

15 HS Candidiasis Another remarkable aspect of this condition is that it manifests only on recovery from prolonged periods of neutropenia. The other near constant finding is one of a group of abdominal symptoms. Right upper quadrant tenderness, hepatomegaly, abdominal distension, nausea, vomiting and diarrhoea occur with variable frequency.

16 HS Candidiasis Liver Function Tests. One of the most consistent biochemical findings in hepatosplenic candidiasis is a marked elevation on serum alkaline phosphatase. White Blood Count. Another commonly reported finding among patients with CDC is rebound leukocytosis Unfortunately, these laboratory changes are very similar to those found in cases of GVHD and sepsisrelated cholestatic liver disease, thus confusing the diagnosis

17 Deep Organ Candidiasis Abdomen (Peritonitis) Peritoneal Dialysis-related Candida Peritonitis Gut-injury Related Candida Peritonitis Bone & Joint Candidiasis Candida Osteomyelitis Candida Arthritis Brain & Nerves (CNS candidiasis) Neurosurgery-related CNS candidiasis Eye (Endophthalmitis) Gallbladder (Biliary Candidiasis) Heart (Cardiac Candidiasis) Lung (Candida Pneumonia) Kidney & Bladder (Urinary Candidiasis) Fungus Balls in Urinary Tract Asymptomatic Funguria Liver & Spleen (Hepatosplenic Candidiasis) Pancreas (Pancreatic Candidiasis)

18 Pneumocystis Jiroveci Pneumonia Normal flora in healthy competent individuals Normally seen as a reactivation in immunocompromised patients Traditionally an AIDS defining illness but seen in any immunocompromised pt Haematology, oncology and solid organ transplant pts Previously Pneumocystis carinii (PCP)

19 PJP Main symptom, exertional dyspnoea Marked desaturation Its actually a fungus Send deep samples for PJP PCR Sputum not ideal but better than nothing BAL is the gold standard

20 PJP

21 PJP Rx Treat with Septrin HD Atovaquone suspension - However, oral atovaquone has limited and unpredictable bioavailability Dapsone with trimethoprim - dapsone is given intravenously or occasionally in nebulised form in the treatment of PCP. Clindamycin with primaquine (unlicensed use in the UK) Aerosolised pentamidine isetionate is no longer recommended because it is associated with increased frequency of relapse Must receive 21 days total treatment

22 Crytococcus Characteristic features: Yeast forms capsule (seen on india ink stain)

23 Cryptococcus neoformans

24 Cryptococcus 34 species in the genus C. neoformans only one of real importance though case reports of other sp causing disease. 2 varieties exist: C. neoformans var neoformans and var gattii

25 Cryptococcus var neoformans found worldwide pigeon droppings soil Serotypes A, D & AD var gattii Tropical and subtropical eucalyptus trees Serotypes B & C

26 Cryptococcus Disease Organism inhaled-usually no or mild symptoms. pneumonia rare even in immunocompromised Meningitis-strongly neurotropic often subacute onset in immunocompetent Immunocompromised-HIV, transplant

27 Cryptococcus Diagnosis Microscopy of CSF Culture-CSF, Blood Anitgen-Blood, CSF

28 Aspergillus Most common mould infection but not all mould infections are aspergillus Diagnostics are poor so clinical diagnosis is key Fungi are angioinvasive so blood/sputum are rarely positive even by PCR Consider B-Glucan and galactomannan based on local policy

29 Aspergillus

30 Gram Stain

31 Sites of Infection Categories Colonization Allergic bronchopulmonary aspergillosis Pulmonary aspergilloma Invasive aspergillosis Sites Involved Sinuses, lungs Sinuses, lungs Pre-existing lung cavity - Pulmonary aspergillosis 1 - CNS aspergillosis - Sinonasal aspergillosis - Osteomyelitis - Endophthalmitis - Endocarditis - Renal abscesses - Cutaneous Others - Cutaneous: burns, post surgical wounds, IV insertion sites, etc. - Otomycosis - Exogenous endophthalmitis - Allergic fungal sinusitis - Urinary tract fungus balls 1This is the most common site of primary invasive aspergillosis.

32 Aspergilloma Colonise pre-existing cavities May be excised as can erode through and cause haemoptysis

33 Invasive Apergillosis

34 Invasive Apergillosis

35

36 18 mo girl with leukaemia

37

38 Other Moulds Zygomycetes Causes mucormyosis Rhinocerebral mucor, high mortality Fusarium Disseminated infection

39

40

41 THE END

Common Fungi. Catherine Diamond MD MPH

Common Fungi. Catherine Diamond MD MPH Common Fungi Catherine Diamond MD MPH Birth Month and Day & Last Four Digits of Your Cell Phone # BEFORE: http://tinyurl.com/kvfy3ts AFTER: http://tinyurl.com/lc4dzwr Clinically Common Fungi Yeast Mold

More information

ECMM Excellence Centers Quality Audit

ECMM Excellence Centers Quality Audit ECMM Excellence Centers Quality Audit Person in charge: Department: Head of Department: Laboratory is accredited according to ISO 15189 (Medical Laboratories Requirements for quality and competence) Inspected

More information

Fungal update. Liise-anne Pirofski, M.D. Albert Einstein College of Medicine

Fungal update. Liise-anne Pirofski, M.D. Albert Einstein College of Medicine Liise-anne Pirofski, M.D. Albert Einstein College of Medicine Fungal update http://clicks.robertgenn.com/miss-potter.php http://letterfromhere.blogspot.com/2007/06/beatrix-potters-jog-trot-through.html

More information

HAEMATOLOGY ANTIFUNGAL POLICY

HAEMATOLOGY ANTIFUNGAL POLICY HAEMATOLOGY ANTIFUNGAL POLICY PROPHYLAXIS Primary Prophylaxis Patient Group Patients receiving intensive remissioninduction chemotherapy for Acute Leukaemia (excluding patients receiving vinca alkaloids)

More information

Epidemiology and ecology of fungal diseases

Epidemiology and ecology of fungal diseases Epidemiology and ecology of fungal diseases Healthcare Focus on: - individual - diagnosis - treatment Public Health Focus on: - population - prevention The nature of fungi Kingdom Fungi (lat. fungus, -i)

More information

Fungal Infections: Reporting. Marcie Tomblyn, MD, MS Associate Member, Moffitt Cancer Center

Fungal Infections: Reporting. Marcie Tomblyn, MD, MS Associate Member, Moffitt Cancer Center Fungal Infections: Management and Reporting Marcie Tomblyn, MD, MS Associate Member, Moffitt Cancer Center February 25, 2010 Objectives Review common fungal infections in HCT patients Review current available

More information

Pulmonary Infections: Fungus. Part I: Background Information and Dimorphic Fungus. Part II: Opportunistic Yeast and Molds

Pulmonary Infections: Fungus. Part I: Background Information and Dimorphic Fungus. Part II: Opportunistic Yeast and Molds Pulmonary Infections: Fungus Part I: Background Information and Dimorphic Fungus Part II: Opportunistic Yeast and Molds Howard J. Sachs, MD www.12daysinmarch.com Classification: Unicellular Budding Yeast,

More information

Prophylaxis versus Diagnostics-driven approaches to treatment of Invasive fungal diseases. Y.L. Kwong Department of Medicine University of Hong Kong

Prophylaxis versus Diagnostics-driven approaches to treatment of Invasive fungal diseases. Y.L. Kwong Department of Medicine University of Hong Kong Prophylaxis versus Diagnostics-driven approaches to treatment of Invasive fungal diseases Y.L. Kwong Department of Medicine University of Hong Kong Pathogenic yeast Candida Cryptococcus Trichosporon Pathogenic

More information

Fungal biology. Fungal Infections. Fungal cell structure. Pathogenesis

Fungal biology. Fungal Infections. Fungal cell structure. Pathogenesis Fungal Infections Once exotic and rare; now increasingly common Fungi are not virulent But they are good at taking advantage Opportunistic in many senses Fungal biology Eukaryotic (organized nucleus and

More information

Introduction. Study of fungi called mycology.

Introduction. Study of fungi called mycology. Fungi Introduction Study of fungi called mycology. Some fungi are beneficial: ex a) Important in production of some foods, ex: cheeses, bread. b) Important in production of some antibiotics, ex: penicillin

More information

Condition First line Alternative Comments Candidemia Nonneutropenic adults

Condition First line Alternative Comments Candidemia Nonneutropenic adults Recommendations for the treatment of candidiasis. Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America. Condition First line Alternative

More information

Title: Author: Speciality / Division: Directorate:

Title: Author: Speciality / Division: Directorate: Antifungal guidelines for CANDIDIASIS INFECTIONS (Adults) Proven infection: Targeted antifungal therapy should be prescribed for: o Positive cultures from a sterile site with clinical or radiological abnormality

More information

Fungal infections in ICU. Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia

Fungal infections in ICU. Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia Fungal infections in ICU Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia Epidemiology of invasive fungal infections - US +300% Martin GS, et al. N Engl J Med 2003;348:1546-1554

More information

Fungal biology. Pathogenesis. Fungal cell structure. Fungal Infections MID 25 & 26. Eukaryotic (organized nucleus and cell structure) Non-motile

Fungal biology. Pathogenesis. Fungal cell structure. Fungal Infections MID 25 & 26. Eukaryotic (organized nucleus and cell structure) Non-motile Fungal Infections Once exotic and rare; now increasingly common Fungi are not virulent But they are good at taking advantage Opportunistic in many senses Fungal biology Eukaryotic (organized nucleus and

More information

Mycobacteria and fungal infections of the respiratory tract

Mycobacteria and fungal infections of the respiratory tract Before you start: You must read the slides! The Dr. did not bother to explain them all Mycobacteria and fungal infections of the respiratory tract - TB is a global problem that the WHO is trying to combat.

More information

Pathogens with Intermediate Virulence Dermatophytes opportunistic Pathogens

Pathogens with Intermediate Virulence Dermatophytes opportunistic Pathogens Pathogens with Intermediate Virulence Dermatophytes opportunistic Pathogens Cryptococcus neoformans Candida albicans Aspergillus species Pneumocystis carinii 1 Dermatophytes Named for derma skin Cause

More information

Case Studies in Fungal Infections and Antifungal Therapy

Case Studies in Fungal Infections and Antifungal Therapy Case Studies in Fungal Infections and Antifungal Therapy Wayne L. Gold MD, FRCPC Annual Meeting of the Canadian Society of Internal Medicine November 4, 2017 Disclosures No financial disclosures or industry

More information

MANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS

MANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS MANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS Paul D. Holtom, MD Associate Professor of Medicine and Orthopaedics USC Keck School of Medicine Numbers of Cases of Sepsis in the United States, According

More information

Management of fungal infection

Management of fungal infection Management of fungal infection HKDU symposium 17 th May 2015 Speaker: Dr. Thomas Chan MBBS (Hons), MRCP, FHKCP, FHKAM Synopsis Infection caused by fungus mycoses Skin infection by fungus is common in general

More information

Rheem Totah, Office H172M, Ph Office hours MWF 11:30 12:20 or by arrangement

Rheem Totah, Office H172M, Ph Office hours MWF 11:30 12:20 or by arrangement Rheem Totah, Office H172M, Ph 206-543-9481 rtotah@uw.edu Office hours MWF 11:30 12:20 or by arrangement Date/Time Topic Readings Mon March 26 Antifungal agents Foye s Chapter 40 Wed March 28 Antifungal

More information

Research priorities in medical mycology

Research priorities in medical mycology Research priorities in medical mycology David W. Denning National Aspergillosis Centre University Hospital of South Manchester The University of Manchester Agenda How many patients are there with serious

More information

ASPERGILLOSIS IN THE NON-NEUTROPENIC HOST

ASPERGILLOSIS IN THE NON-NEUTROPENIC HOST ASPERGILLOSIS IN THE NON-NEUTROPENIC HOST Dr J Garbino University Hospital Geneva ASPERGILLOSIS IN THE NON-NEUTROPENIC HOST INTRODUCTION SWISS ASPERGILLOSIS SURVEY IN THE NON-NEUTROPENIC HOST Introduction

More information

Pneumocystis. Pneumocystis BIOL Summer Introduction. Mycology. Introduction (cont.) Introduction (cont.)

Pneumocystis. Pneumocystis BIOL Summer Introduction. Mycology. Introduction (cont.) Introduction (cont.) Introduction Pneumocystis Disclaimer: This lecture slide presentation is intended solely for educational purposes. Many of the images contained herein are the property of the original owner, as indicated

More information

Fungal Infection Post-Infusion Data

Fungal Infection Post-Infusion Data Fungal Infection Post-Infusion Data Registry Use Only Sequence Number: Date Received: CIBMTR Center Number: Event date: / / Visit: 100 day 6 months 1 year 2 years >2 years. Specify: CIBMTR Form 2146 revision

More information

WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS?

WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS? WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS? Assoc. Prof. Dr. Serkan SENER Acibadem University Medical School Department of Emergency Medicine, Istanbul Acibadem Ankara Hospital,

More information

Opportunistic Mycoses

Opportunistic Mycoses CANDIDIASIS SOFYAN LUBIS DEPARTEMEN MIKROBIOLOGI FAK.KEDOKTERAN USU MEDAN 2009 Opportunistic Mycoses Opportunistic mycoses are fungal infections that do not normally cause disease in healthy people, but

More information

Fungal Infections. Alessandro Diana November 22th 2007

Fungal Infections. Alessandro Diana November 22th 2007 Fungal Infections Alessandro Diana November 22th 2007 alessandro.diana@ne.ch Topics Aspergillosis Candidiasis Cryptococcosis Histoplasmosis Coccidioidomycosis Blastomyocosis Sporotrichosis Pneumocystis

More information

PAGL Inclusion Approved at January 2017 PGC

PAGL Inclusion Approved at January 2017 PGC Guideline for the prophylaxis and treatment of fungal infections in Haematology patients 1. Introduction PAGL Inclusion Approved at January 2017 PGC Haematology, CHUGGS June 2016 This guideline sets out

More information

Elements for a Public Summary. [Product Name] 40 mg/ml oral suspension. VI.2.1 Overview of disease epidemiology

Elements for a Public Summary. [Product Name] 40 mg/ml oral suspension. VI.2.1 Overview of disease epidemiology VI.2 Elements for a Public Summary [Product Name] 40 mg/ml oral suspension VI.2.1 Overview of disease epidemiology Fungi (yeasts) are small organisms that feed by breaking down tissue. In humans, fungi

More information

Fungal infections and critically ill adults

Fungal infections and critically ill adults Martin Beed FRCA FFICM DM Richard Sherman MRCP FRCA FFICM Stephen Holden MSc FRCPath 1A02,2C03 Key points The incidence of fungal diseases in critically ill patients is thought to be increasing, most commonly

More information

Voriconazole October 2015 Risk Management Plan. Voriconazole

Voriconazole October 2015 Risk Management Plan. Voriconazole Voriconazole October 2015 VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Invasive aspergillosis (IA) is the most devastating of Aspergillus related diseases, targeting severely

More information

Introduction Medical Mycology. Prof. Dr. Asem Shehabi Faculty of Medicine University of Jordan

Introduction Medical Mycology. Prof. Dr. Asem Shehabi Faculty of Medicine University of Jordan Introduction Medical Mycology Prof. Dr. Asem Shehabi Faculty of Medicine University of Jordan General Fungi-1 Medical Mycology deals with fungi cause human diseases directly (mycoses, allergies) or indirectly

More information

Fungal Infection Pre-Infusion Data

Fungal Infection Pre-Infusion Data Fungal Infection Pre-Infusion Data Registry Use Only Sequence Number: Date Received: CIBMTR Center Number: Event date: / / CIBMTR Form 2046 revision 5 (page 1 of 5). Last Updated May, 2018. Infection Episode

More information

Fungi are eukaryotic With rigid cell walls composed largely of chitin rather than peptidoglycan (a characteristic component of most bacterial cell

Fungi are eukaryotic With rigid cell walls composed largely of chitin rather than peptidoglycan (a characteristic component of most bacterial cell Antifungal Drugs Fungal infections (Mycoses) Often chronic in nature. Mycotic infections may be superficial and involve only the skin (cutaneous mycoses extending into the epidermis) Others may penetrate

More information

CURRENT AND NEWER ANTI-FUNGAL THERAPIES- MECHANISMS, INDICATIONS, LIMITATIONS AND PROBLEMS. Dr AMIT RAODEO DM SEMINAR

CURRENT AND NEWER ANTI-FUNGAL THERAPIES- MECHANISMS, INDICATIONS, LIMITATIONS AND PROBLEMS. Dr AMIT RAODEO DM SEMINAR CURRENT AND NEWER ANTI-FUNGAL THERAPIES- MECHANISMS, INDICATIONS, LIMITATIONS AND PROBLEMS Dr AMIT RAODEO DM SEMINAR Introduction The incidence of invasive fungal infections in critically ill intensive

More information

Candiduria in ICU : when and how to treat? Dr. Debashis Dhar Dept of Critical Care and Emergency Medicine Sir Ganga Ram Hospital

Candiduria in ICU : when and how to treat? Dr. Debashis Dhar Dept of Critical Care and Emergency Medicine Sir Ganga Ram Hospital Candiduria in ICU : when and how to treat? Dr. Debashis Dhar Dept of Critical Care and Emergency Medicine Sir Ganga Ram Hospital Introduction Nosocomial bacteriuria or candiduria develops in up to 25%

More information

Antifungal Update 2/22/12. Which is the most appropriate initial empirical therapy in a candidemic patient?

Antifungal Update 2/22/12. Which is the most appropriate initial empirical therapy in a candidemic patient? Antifungal Update B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy School of Pharmacy University of California San Francisco 3/3 blood cultures are positive for an unidentified

More information

Antimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association

Antimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association Antimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association Els Vandecasteele, Jan De Waele, Dominique Vandijck, Stijn Blot, Dirk

More information

Neutropenic Sepsis Guideline

Neutropenic Sepsis Guideline Neutropenic Sepsis Guideline Neutropenic Sepsis Guideline - definitions Suspected or proven infection in a neutropenic patient is a MEDICAL EMERGENCY and is an indication for immediate assessment and prompt

More information

Fungal Infections. Fungal Infections

Fungal Infections. Fungal Infections Fungal Infection in the Immune Competent Host Steven L. Primack, MD Fungal Infection in the Immune Competent Host Steven L. Primack, MD Department of Radiology Oregon Health & Science University Fungal

More information

Cigna Drug and Biologic Coverage Policy

Cigna Drug and Biologic Coverage Policy Cigna Drug and Biologic Coverage Policy Subject Voriconazole Effective Date... 3/15/2018 Next Review Date... 3/15/2019 Coverage Policy Number... 4004 Table of Contents Coverage Policy... 1 General Background...

More information

Mycological Profile of Bronchial Wash Specimens in Patients with Lower Respiratory Tract Infections

Mycological Profile of Bronchial Wash Specimens in Patients with Lower Respiratory Tract Infections International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 11 (2017) pp. 176-182 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.611.022

More information

Trust Guideline for the Use of Antifungals in Adults

Trust Guideline for the Use of Antifungals in Adults For Use in: By: For: Division responsible for document: Key words: Name of document author: Job title of document author: Name of document author s Line Manager: Job title of author s Line Manager: Supported

More information

Lethal pulmonary fungal disease think fungus early

Lethal pulmonary fungal disease think fungus early Lethal pulmonary fungal disease think fungus early David W. Denning National Aspergillosis Centre University Hospital of South Manchester The University of Manchester Global Action Fund for Fungal Infections

More information

Antifungal Update. Candida: In Vitro Antifungal Susceptibility Testing

Antifungal Update. Candida: In Vitro Antifungal Susceptibility Testing Antifungal Update B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy School of Pharmacy University of California San Francisco The patient spikes a new fever and 3/3 blood

More information

ADEQUATE ANTIFUNGAL USE FOR BLOODSTREAM INFECTIONS

ADEQUATE ANTIFUNGAL USE FOR BLOODSTREAM INFECTIONS ADEQUATE ANTIFUNGAL USE FOR BLOODSTREAM INFECTIONS COMMERCIAL RELATIONS DISCLOSURE 2500 9000 15000 Astellas Gilead Sciences Pfizer Inc Expert advice Speaker s bureau Speaker s bureau OUTLINE OF THE PRESENTATION

More information

High risk neutropenic patient (anticipated duration > 10 days) Send blood twice weekly for Beta -D Glucan Galactomanan Aspergillus PCR

High risk neutropenic patient (anticipated duration > 10 days) Send blood twice weekly for Beta -D Glucan Galactomanan Aspergillus PCR DERBY TEACHING HOSPITALS NHS FOUNDATION TRUST Prophylaxis, diagnosis and treatment of invasive fungal infections in oncology/haematology patients with prolonged neutropenia. High risk neutropenic patient

More information

Nationwide survey of treatment for pediatric patients with invasive fungal infections in Japan

Nationwide survey of treatment for pediatric patients with invasive fungal infections in Japan J Infect Chemother (2013) 19:946 950 DOI 10.1007/s10156-013-0624-7 ORIGINAL ARTICLE Nationwide survey of treatment for pediatric patients with invasive fungal infections in Japan Masaaki Mori Received:

More information

Latest Press Release. Cloud9games.tk

Latest Press Release. Cloud9games.tk corp@stantec.com Latest Press Release Cloud9games.tk S (Dorland, 27th ed); Infection with a fungus of the genus candida; usually a superficial infection of the moist areas of the body and is generally

More information

OPPORTUNISTIC MYCOSES

OPPORTUNISTIC MYCOSES OPPORTUNISTIC MYCOSES Candida yeasts that is, fungi that exist predominantly in a unicellular form. small (4-6 µm), thin-walled, ovoid cells (blastospores) that reproduce by budding. do not require special

More information

Use of Antifungal Drugs in the Year 2006"

Use of Antifungal Drugs in the Year 2006 Use of Antifungal Drugs in the Year 2006" Jose G. Montoya, MD Associate Professor of Medicine Associate Chief for Clinical Affairs Division of Infectious Diseases Stanford University School of Medicine

More information

ESCMID Online Lecture Library. by author. CASE PRESENTATION ECCMID clinical grand round May Anat Stern, MD Rambam medical center Haifa, Israel

ESCMID Online Lecture Library. by author. CASE PRESENTATION ECCMID clinical grand round May Anat Stern, MD Rambam medical center Haifa, Israel CASE PRESENTATION ECCMID clinical grand round May 2014 Anat Stern, MD Rambam medical center Haifa, Israel An 18 years old Female, from Ukraine, diagnosed with acute lymphoblastic leukemia (ALL) in 2003.

More information

EMPIRICAL PRESCRIBING GUIDELINES FOR SYSTEMIC FUNGAL INFECTIONS IN ADULTS - HH (1)/CL(G)/651/13

EMPIRICAL PRESCRIBING GUIDELINES FOR SYSTEMIC FUNGAL INFECTIONS IN ADULTS - HH (1)/CL(G)/651/13 Hampshire Hospitals NHS Foundation Trust Empirical Antifungal Prescribing Guidelines [INSERT UNIQUE POLICY IDENTIFIER] Due for latest review on January 2015. CHECK THE INTRANET FOR LATEST VERSION EMPIRICAL

More information

Antifungal Agents - Cresemba (isavuconazonium), Vfend. Prior Authorization Program Summary

Antifungal Agents - Cresemba (isavuconazonium), Vfend. Prior Authorization Program Summary Antifungal Agents - Cresemba (isavuconazonium), Noxafil (posaconazole), Vfend (voriconazole) Prior Authorization Program Summary FDA APPROVED INDICATIONS DOSAGE 1,2,14 Drug FDA Indication(s) Dosing Cresemba

More information

EMERGING FUNGAL INFECTIONS IN IMMUNOCOMPROMISED PATIENTS

EMERGING FUNGAL INFECTIONS IN IMMUNOCOMPROMISED PATIENTS EMERGING FUNGAL INFECTIONS IN IMMUNOCOMPROMISED PATIENTS DR LOW CHIAN YONG MBBS, MRCP(UK), MMed(Int Med), FAMS Consultant, Dept of Infectious Diseases, SGH Introduction The incidence of invasive fungal

More information

PROGRESSI NELLA TERAPIA ANTIFUNGINA. A tribute to Piero Martino

PROGRESSI NELLA TERAPIA ANTIFUNGINA. A tribute to Piero Martino PROGRESSI NELLA TERAPIA ANTIFUNGINA A tribute to Piero Martino 1946-2007 ITALIAN ICONS IERI, OGGI, E DOMANI IERI, OGGI, E DOMANI IERI, OGGI, E DOMANI 1961 CAUSES OF DEATH IN PATIENTS WITH MALIGNANCIES

More information

An Update in the Management of Candidiasis

An Update in the Management of Candidiasis An Update in the Management of Candidiasis Daniel B. Chastain, Pharm.D., AAHIVP Infectious Diseases Pharmacy Specialist Phoebe Putney Memorial Hospital Adjunct Clinical Assistant Professor UGA College

More information

Antifungal Update 2/24/11. Which is the most appropriate initial empirical therapy in a candidemic patient?

Antifungal Update 2/24/11. Which is the most appropriate initial empirical therapy in a candidemic patient? Antifungal Update B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy School of Pharmacy University of California San Francisco The patient spikes a new fever and 3/3 blood

More information

Advance laboratory diagnosis of fungal meningitis: A mini review

Advance laboratory diagnosis of fungal meningitis: A mini review INT J CURR SCI 2013, 6: E 46-50 REVIEW ISSN 2250-1770 Advance laboratory diagnosis of fungal meningitis: A mini review *Biswajit Batabyal a, Bappa Mandal b, Dwaipayan Saha c and Sukanta Chakraborty d a

More information

Use of Antifungals in the Year 2008

Use of Antifungals in the Year 2008 Use of Antifungals in the Year 2008 Jose G. Montoya, MD Associate Professor of Medicine Associate Chief for Clinical Affairs Division of Infectious Diseases Stanford University School of Medicine Diagnosis

More information

Fungal Meningitis. Stefan Zimmerli Institute for infectious diseases University of Bern Friedbühlstrasse Bern

Fungal Meningitis. Stefan Zimmerli Institute for infectious diseases University of Bern Friedbühlstrasse Bern Fungal Meningitis Stefan Zimmerli Institute for infectious diseases University of Bern Friedbühlstrasse 51 3010 Bern Death due to infectious diseases in sub-saharan Africa Park BJ. Et al AIDS 2009;23:525

More information

Outline NEW DIAGNOSTIC TOOLS WHY? WHICH TESTS? WHEN TO USE THEM? Documented IFI

Outline NEW DIAGNOSTIC TOOLS WHY? WHICH TESTS? WHEN TO USE THEM? Documented IFI New Developments and Challenges in Diagnostics of Invasive Fungal Infections O. Marchetti, MD Infectious Diseases Service, Department of Medicine, CHUV and University of Lausanne, Switzerland Workshop

More information

Fungi GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 53: Author Moi Lin Ling, MBBS, FRCPA, CPHQ, MBA

Fungi GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 53: Author Moi Lin Ling, MBBS, FRCPA, CPHQ, MBA GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 53: Fungi Author Moi Lin Ling, MBBS, FRCPA, CPHQ, MBA Chapter Editor Ziad A. Memish, MD, FRCPC, FACP Cover heading - Topic Outline Topic outline

More information

Antifungal drugs Dr. Raz Muhammed

Antifungal drugs Dr. Raz Muhammed Antifungal drugs 13. 12. 2018 Dr. Raz Muhammed 2. Flucytosine (5-FC) Is fungistatic Is a synthetic pyrimidine antimetabolite Is often used in combination with amphotericin B in the treatment of systemic

More information

Current options of antifungal therapy in invasive candidiasis

Current options of antifungal therapy in invasive candidiasis Current options of antifungal therapy in invasive candidiasis Saloua Ladeb Bone Marrow Transplant Center Tunis HAMMAMET 24 th April 2012 DEFINITION One or more positive results on blood culture for Candida

More information

CMV. Inclusions predominantly in endothelial cells. Immunostaining greater sensitivity than H&E alone.

CMV. Inclusions predominantly in endothelial cells. Immunostaining greater sensitivity than H&E alone. CMV Inclusions predominantly in endothelial cells. Immunostaining greater sensitivity than H&E alone. CMV inclusions are often present in a very patchy distribution Carefully examine all levels CMV CMV

More information

Fungi More or Less Obligately Associated with Humans. Requirements for Designating a Mycosis*

Fungi More or Less Obligately Associated with Humans. Requirements for Designating a Mycosis* P Fungi More or Less Obligately Associated with Humans a. a few dermatophytes (the anthropophilic species ) b. Malassezia furfur c. Candida albicans d. + Lacazia (Loboa) loboi*p e. + Pneumocystis jirovecii*p

More information

Fungal and Viral Infections

Fungal and Viral Infections CHAPTER 89 Fungal and Viral Infections Palash Samanta, Ghady Haidar, Minh Ly Nguyen, Cornelius J. Clancy, and M. Hong Nguyen FUNGAL INFECTIONS Fungal Pathogens Medically relevant fungi are classically

More information

Epidemiology and Laboratory Diagnosis of Fungal Diseases

Epidemiology and Laboratory Diagnosis of Fungal Diseases Medical Mycology (BIOL 4849) Summer 2007 Dr. Cooper Epidemiology of Mycoses Epidemiology and Laboratory Diagnosis of Fungal Diseases Mycosis (pl., mycoses) - an infection caused by a fungus Two broad categories

More information

Study of systemic fungal infections in renal transplant recipients

Study of systemic fungal infections in renal transplant recipients Original Research Article Study of systemic fungal infections in renal transplant recipients N.D. Srinivasaprasad 1*, G. Chandramohan 1, M. Edwin Fernando 2 1 DM (Nephrology), Assistant Professor, 2 DM

More information

Antifungal prophylaxis in haematology patients: the role of voriconazole

Antifungal prophylaxis in haematology patients: the role of voriconazole REVIEW 10.1111/j.1469-0691.2012.03772.x Antifungal prophylaxis in haematology patients: the role of voriconazole Y. Hicheri 1, G. Cook 2 and C. Cordonnier 1 1) Service d Hématologie Clinique, Assistance

More information

Summary of the risk management plan (RMP) for Cresemba (isavuconazole)

Summary of the risk management plan (RMP) for Cresemba (isavuconazole) EMA/576866/2015 Summary of the risk management plan (RMP) for Cresemba (isavuconazole) This is a summary of the risk management plan (RMP) for Cresemba, which details the measures to be taken in order

More information

Fungal Infections in Neutropenic Hematological Disorders

Fungal Infections in Neutropenic Hematological Disorders Fungal Infections in Neutropenic Hematological Disorders 23 Dr Farah Jijina 24 Fungal Infections in Neutropenic Hematological Disorders 25 Dr Farah Jijina 26 Fungal Infections in Neutropenic Hematological

More information

Fungi. Eucaryotic Rigid cell wall(chitin, glucan) Cell membrane ergosterol Unicellular, multicellular Classic fungus taxonomy:

Fungi. Eucaryotic Rigid cell wall(chitin, glucan) Cell membrane ergosterol Unicellular, multicellular Classic fungus taxonomy: MYCOLOGY Mycology I Fungi Eucaryotic Rigid cell wall(chitin, glucan) Cell membrane ergosterol Unicellular, multicellular Classic fungus taxonomy: Morphology Spore formation FFungi Yeast Mold Yeastlike

More information

Is pre-emptive therapy a realistic approach?

Is pre-emptive therapy a realistic approach? Is pre-emptive therapy a realistic approach? J Peter Donnelly PhD, FRCPath Department of Haematology Radboud University Nijmegen Medical Centre Nijmegen, The Netherlands Is pre-emptive therapy a realistic

More information

Antifungals and current treatment guidelines in pediatrics and neonatology

Antifungals and current treatment guidelines in pediatrics and neonatology Dragana Janic Antifungals and current treatment guidelines in pediatrics and neonatology Dragana Janic. University Children`s Hospital, Belgrade, Serbia 10/10/17 Hotel Crowne Plaza, Belgrade, Serbia; www.dtfd.org

More information

Histopathology Description:

Histopathology Description: 2013-2-1 CANINE HEART Ahmed M. Abubakar BOVINE PATHOLOGY CONTRIBUTING INSTITUTION : The Royal Veterinary college, Dept. of Pathology and Biology Signalment: 11-month-old male Border Collie dog (Canis familiaris)

More information

Cryptococcus gattii Fungal Meningitis. By Cassy Hedberg BI 234

Cryptococcus gattii Fungal Meningitis. By Cassy Hedberg BI 234 Cryptococcus gattii Fungal Meningitis By Cassy Hedberg BI 234 This disease s deadliest weapon is the fact you ve never heard of it -Kausik Datta, Post-doctoral Fellow at Johns Hopkins Medicine A deadly

More information

Epidemiology of Fungal Diseases

Epidemiology of Fungal Diseases Lecture 2 Epidemiology of Fungal Diseases Disclaimer: This lecture slide presentation is intended solely for educational purposes. Many of the images contained herein are the property of the original owner,

More information

Antifungal therapies differences in agents

Antifungal therapies differences in agents Antifungal therapies differences in agents The basic Fungi are eukaryotes Eukaryote = an organism whose cells contain complex structures enclosed within membrane. Most Common Fungal Pathogens Dermatophytes

More information

The sensitivity of fungal microorganisms to fluconazole is as follows:

The sensitivity of fungal microorganisms to fluconazole is as follows: FLUCAN Composition Each capsule contains Fluconazole 50, 100 or 150 mg Capsules Action Fluconazole is a triazole anti-fungal, which in sensitive fungi, inhibits cytochrome P450-dependent enzymes resulting

More information

Fever. National Pediatric Nighttime Curriculum Written by Debbie Sakai, M.D. Institution: Lucile Packard Children s Hospital

Fever. National Pediatric Nighttime Curriculum Written by Debbie Sakai, M.D. Institution: Lucile Packard Children s Hospital Fever National Pediatric Nighttime Curriculum Written by Debbie Sakai, M.D. Institution: Lucile Packard Children s Hospital Case 1 4-month-old well-appearing girl admitted for croup and respiratory distress.

More information

Invasive Fungal Infections in Solid Organ Transplant Recipients

Invasive Fungal Infections in Solid Organ Transplant Recipients Outlines Epidemiology Candidiasis Aspergillosis Invasive Fungal Infections in Solid Organ Transplant Recipients Hsin-Yun Sun, M.D. Division of Infectious Diseases Department of Internal Medicine National

More information

London New Drugs Group APC/DTC Briefing

London New Drugs Group APC/DTC Briefing London New Drugs Group APC/DTC Briefing Posaconazole for invasive fungal infections Contents Background 2 Dosing Information 3 Clinical evidence for treatment of infections 3 Clinical evidence for prophyactic

More information

How to make a fast diagnosis

How to make a fast diagnosis How to make a fast diagnosis 8 th Advances Against Aspergillosis 1 3 February 2018 Lisbon, Portugal Cornelia Lass-Flörl Division of Hygiene and Medical Microbiology Innsbruck Medical University Division

More information

General History. 林陳 珠 Female 69 years old 住院期間 : ~ Chief Complaint : sudden loss of conscious 5 minutes in the morning.

General History. 林陳 珠 Female 69 years old 住院期間 : ~ Chief Complaint : sudden loss of conscious 5 minutes in the morning. General History 林陳 珠 Female 69 years old 住院期間 : 93.5.8~93.5.15 Chief Complaint : sudden loss of conscious for 2-52 5 minutes in the morning. General History DM under regular medical control for 10 years.

More information

Cryptococcosis*,** *usually considered to be an opportunistic mycosis that often becomes systemic.

Cryptococcosis*,** *usually considered to be an opportunistic mycosis that often becomes systemic. Cryptococcosis*,** Definition - a chronic, subacute or rarely acute pulmonary, systemic or meningitic infection caused by Cryptococcus neoformans - the encapsulated Blastomycetes anamorph of Filobasidiella

More information

FLUCAND HIKMA PHARMACEUTICALS

FLUCAND HIKMA PHARMACEUTICALS 09-15 FLUCAND HIKMA PHARMACEUTICALS (Fluconazole) Description Flucand is a crystalline white - whitish powder, which is slightly soluble in water and in a saline solution. Its molecular weight is 306.3.

More information

Ventilator Associated Pneumonia. ICU Fellowship Training Radboudumc

Ventilator Associated Pneumonia. ICU Fellowship Training Radboudumc Ventilator Associated Pneumonia ICU Fellowship Training Radboudumc Attributable mortality VAP Meta-analysis of individual patient data from randomized prevention studies Attributable mortality mainly results

More information

2/18/19. Case 1. Question

2/18/19. Case 1. Question Case 1 Which of the following can present with granulomatous inflammation? A. Sarcoidosis B. Necrobiotic xanthogranulma C. Atypical mycobacterial infection D. Foreign Body Reaction E. All of the above

More information

Dr Hamed Alzoubi. Fungal infections

Dr Hamed Alzoubi. Fungal infections Dr Hamed Alzoubi Fungal infections Skin & subcutaneous Mycoses 1-Superficial mycoses such as 2-Cutaneous mycoses such as 3-Subcutaneous mycoses Tinea versicolor or Pityriasis versicolor Ring worm or Tinea

More information

Severe β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy

Severe β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy Recommended Empirical Antibiotic Regimens for MICU Patients Notes: The antibiotic regimens shown are general guidelines and should not replace clinical judgment. Always assess for antibiotic allergies.

More information

number Done by Corrected by Doctor د.حامد الزعبي

number Done by Corrected by Doctor د.حامد الزعبي number Fungi#1 Done by نرجس الس ماك Corrected by مهدي الشعراوي Doctor د.حامد الزعبي Introduction to Mycology -Terms: -Medical Mycology: The study of mycosis and their etiological agents -Mycosis: Disease

More information

Fungal infections. Ematologia. Corrado Girmenia. Ematologia, Azienda Policlinico Umberto I Sapienza University of Rome, Italy

Fungal infections. Ematologia. Corrado Girmenia. Ematologia, Azienda Policlinico Umberto I Sapienza University of Rome, Italy Fungal infections Corrado Girmenia Ematologia, Azienda Policlinico Umberto I Sapienza University of Rome, Italy Ematologia Epidemiology Diagnostic approach Prevention strategies Monitoring of IFDs in

More information

MICROBIOLOGICAL TESTING IN PICU

MICROBIOLOGICAL TESTING IN PICU MICROBIOLOGICAL TESTING IN PICU This is a guideline for the taking of microbiological samples in PICU to diagnose or exclude infection. The diagnosis of infection requires: Ruling out non-infectious causes

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author How To Best Use Antifungal Agents Cornelia Lass-Flörl Division of Hygiene and Medical Microbiology Innsbruck Medical University ESCMID SUMMER SCHOOL 2012 Epidemiology Diagnosis Roadmap Antifungal drugs

More information

Antifungals in Invasive Fungal Infections: Antifungals in neutropenic patients

Antifungals in Invasive Fungal Infections: Antifungals in neutropenic patients BVIKM-SBIMC La Hulpe, 6 November 2008 Antifungals in Invasive Fungal Infections: Antifungals in neutropenic patients Johan Maertens, MD Acute Leukemia and SCT Unit University Hospital Gasthuisberg Catholic

More information

Dr Kaniz Fatema. FCPS (Medicine), MD (Critical Care Medicine) Associate Professor Dept of Critical Care Medicine BIRDEM General Hospital

Dr Kaniz Fatema. FCPS (Medicine), MD (Critical Care Medicine) Associate Professor Dept of Critical Care Medicine BIRDEM General Hospital Dr Kaniz Fatema FCPS (Medicine), MD (Critical Care Medicine) Associate Professor Dept of Critical Care Medicine BIRDEM General Hospital 65-years old lady HTN (15 yrs) Adult Still s Disease (2 mon)

More information

number Done by Corrected by Doctor

number Done by Corrected by Doctor number 19 Done by عمرسامي Corrected by حسام أبو عوض Doctor حامد الزعبي Fungal infections - Fungal infections are infections caused by fungi, a type of microorganisms. Which sites are mostly affected? -

More information

Primary Antifungal Prophylaxis in Adult Hematopoietic Stem Cell Transplant Recipients: Current Therapeutic Concepts

Primary Antifungal Prophylaxis in Adult Hematopoietic Stem Cell Transplant Recipients: Current Therapeutic Concepts Primary Antifungal Prophylaxis in Adult Hematopoietic Stem Cell Transplant Recipients: Current Therapeutic Concepts Dorothy McCoy, Pharm.D., Daryl D. DePestel, Pharm.D., and Peggy L. Carver, Pharm.D. In

More information